Page 374 - 16Neonatal Jaundice_compressed
P. 374

Neonatal jaundice


              Bibliographic details   Study type &   Patient characteristics                Results                           Reviewers Comments
                                  Evidence level
              Turkey                              transaminase (AST) or alanine transaminase (ALT)   Mean peak conjugated bilirubin
                                                                                            130 ± 130 micromol/litre
              Ref ID:                             Exclusion:
                   121
                                                  Not reported                                Diagnoses in conjugated jaundice
                                                                                            Culture-proven sepsis: 14/42 (35.7%)
                                                  Setting:                                  Perinatal hypoxia-ischemia: 7/42 (16.7%)
                                                  Neonatal Intensive Care Unit
                                                                                            Blood group incompatibility: 5/42 (11.9%)
                                                  Sample Size: 42                           Trisomy 21: 3/42 (7.1%)
                                                                                            TPN-associated cholestasis (3/42 (7.1%)
                                                  Gender M/F: Not reported                  Neonatal hepatitis: 2/42 (4.8%)
                                                  Mean GA: 37 weeks                         Metabolic liver disease: 1/42 (2.4%)
                                                  Mean BW: Not reported
                                                  Ethnicity: Not reported                   Biliary atresia: 1/42 (2.4%)
                                                                                            Portal venous thrombosis: 1/42 (2.4%) Unknown:
                                                                                            4/42 (9.5%)
              Author:             Study type:     Diagnosis: Prolonged Jaundice             Prevalence of prolonged
              Sarlik Y            Case series     Criteria: Jaundiced at day 14             jaundice/hyperbilirubinaemia
                                                  Setting: Neonatal Intensive Care Unit     31/381 (8.1%)
              Year:               Evidence level: 3
             2003                                 Sample Size: 26                           Median bilirubin levels
                                                  Mean GA: 38 weeks                         TSB: 246 micromol/litre
             Country:                             Mean BW: 3164 g
              Turkey                              Gender M/F: 15/11                         Blood group incompatibility: 7/26 (26.9%)
                                                  Ethnicity: Not reported
                   120
              Ref ID:                             Breastfeeding: 96%                        Breast milk jaundice: 14/26 (53.8%)
                                                  Mean age jaundice recognised: 19 days:
                                                                                            Possible Biliary Atresia : 1/26 (3.8%) referred to
                                                  Exclusion: Preterm babies                 pediatric gastroenterology due to direct bilirubin

                                                                                            Inadequate caloric intake: 4/26 (15.4%)

              Author: Hannam S    Study type:     Diagnosis: Prolonged Jaundice             Median bilirubin levels           G6PD testing done where indicated by
                                  Case series     Criteria: jaundiced at day 14             TSB: 179 micromol/litre           ethnic background of baby
              Year: 2000                          Setting: Outpatient                                                         Clinical Examination by a
                                  Evidence level: 3                                         ABO incompatibility: 0/154 (0%)   Paediatrician is vital
              Country: UK                         Sample Size: 154                                                            Recommended Investigations in
                                                  GA (range): 39(37 – 43) weeks             Incidence of G6PD deficiency:     prolonged jaundice
              Ref ID:                             BW (range): 3.2 (1.98 – 4.8 kg            3/59 (5.1%)                              Total & unconugated
                   122
                                                  Gender M/F: 96/58                                                           bilirubin
                                                  Ethnicity: 89 (57%) Caucasian,            Infection (UTI): 2/154 (1.3%)            PCV & G6PD level (where
                                                  36 (23%) Black, 20 (13%) Asian, 9 (6%) Mediterranean                        appropriate)
                                                  Breastfeeding: 96%                        Idiopathic: Not reported                 Urine microscopy &
                                                  Jaundice recognised: Older than 14 days:                                    culture
                                                                                                                                     Inspection of recent stool
                                                  Exclusion: Not reported                                                     sample for bile pigmentation






            260
   369   370   371   372   373   374   375   376   377   378   379